YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Epilepsy Drugs
Advisory Panel Rejects 'Black Box' Warnings of Suicide Risk on Epilepsy Drugs
Jul 11, 2008 | Parker Waichman Alonso LLP
An expert advisory panel refused a Food & Drug Administration (FDA) proposal to place a “Black Box”—the agency’s...
Epilepsy Drugs Targeted for Black Box Suicide Warning
Jul 8, 2008 | Parker Waichman Alonso LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...
Neurontin Should Have Had Depression Warning, Neurologist Says
Jun 20, 2008 | Parker Waichman Alonso LLP
A British neurologist says he advised the maker of Neurontin to include a warning on its label about its potential to cause depression and...
New Suicide Warning for Epilepsy Drugs
Jun 12, 2008 | Parker Waichman Alonso LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior. The...
Epilepsy Drugs to Get Suicide Warnings, FDA Confirms
Jun 6, 2008 | Parker Waichman Alonso LLP
US regulators are very close to finalizing new suicide warnings for 11 epilepsy drugs, The Wall Street Journal reported today. This past...
Epilepsy Drugs May Get New Suicide Warnings, In Spite of Pressure From Big Pharma
Jun 4, 2008 | Parker Waichman Alonso LLP
Federal regulators are considering new suicide warnings for some epilepsy drugs, but the pharmaceutical companies that make the medications are...
Dilantin Linked to Osteoporosis
Apr 30, 2008 | Parker Waichman Alonso LLP
A recent study revealed that the popular epilepsy drug Dilantin might be placing young women who take it for a year or more at higher risk for...
Epilepsy Drug No Help Against Migraines
Feb 12, 2008 | Parker Waichman Alonso LLP
The epilepsy drug oxcarbazepine was strongly believed to have prevented migraine headaches; however, a new study suggests that this is not so. ...
Page 1/1
Defective Drugs
